# Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

> **NCT04345770** · PHASE2 · UNKNOWN · sponsor: **Wuhan University** · enrollment: 100 (estimated)

## Conditions studied

- Malignant Neoplasm of Stomach

## Interventions

- **PROCEDURE:** D2 radical gastrectomy
- **DRUG:** SOX neoadjuvant or postoperative chemotherapy
- **PROCEDURE:** Hyperthermic intraperitoneal chemotherapy (HIPEC)

## Key facts

- **NCT ID:** NCT04345770
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345770, "Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04345770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*